Trade Show

API China 2026: Meet Datwyler at Booth #B4C45

Datwyler exhibits at API China 2026 at the Wuhan International Exhibition Center, November 11–13, connecting with API manufacturers, CDMOs, biopharma developers, and packaging professionals from across China's rapidly expanding pharmaceutical supply chain.

  • Exhibiting at one of China's largest pharmaceutical trade events, November 11–13 in Wuhan
  • Topics: elastomer component selection, GLP-1 drug packaging, and container closure systems for injectable biologics
  • Visit Booth #B4C45 to connect with Datwyler's regional and global experts
Date November 11, 2026 – November 13, 2026
Location Wuhan International Exhibition Center | Wuhan, China
Details Booth #B4C45
Schedule a Meeting View Event Details
Event Overview

Elastomer and Closure Expertise for China's Injectable Drug Market

API China is the preferred platform for more than 5,000 Chinese pharmaceutical enterprises and draws over 60,000 professionals from across the domestic and global pharma industry. Datwyler joins this Wuhan exhibition to engage with the manufacturers and developers at the heart of China's growing injectable biologics, GLP-1, and parenteral drug pipeline. 

Want to connect?

Find us at Booth #B4C45, where our regional and global experts are on hand to explore Datwyler's comprehensive portfolio of:

  • NeoFlex™ and OmniFlex® elastomer platforms for GLP-1 injectables, biologics, and high-value parenteral drug products
  • Container closure systems, including stoppers, plungers, aluminum seals, and tip caps
  • Drug delivery components engineered for auto-injectors, prefilled syringes, and large-volume subcutaneous delivery

All backed by extractables and leachables data, container closure integrity testing, and the regulatory documentation that supports multi-market compliance for Chinese manufacturers targeting domestic and export markets.

Solutions Spotlight

What We're Showcasing at API China

Explore the solutions and technologies most relevant to this event.

GLP-1 and High-Value Injectable Packaging Solutions
Featured Solution

GLP-1 and High-Value Injectable Packaging Solutions

China's GLP-1 and high-value injectable market is growing at pace, and primary packaging must keep up. Datwyler's NeoFlex™ plungers and OmniFlex® stoppers are engineered for the compatibility, purity, and performance that GLP-1 formulations and sensitive biologics demand.
Container Closure Systems for Injectable Drug Products
Featured Solution

Container Closure Systems for Injectable Drug Products

Datwyler's comprehensive container closure portfolio — spanning stoppers, plungers, aluminum seals, and tip caps — is manufactured to FirstLine® quality standards and supported by full regulatory documentation packages. Whether qualifying components for a new injectable program or requalifying an existing supply chain, Datwyler brings the technical depth and supply reliability that Chinese pharmaceutical manufacturers require. 
Drug Delivery Components for Large-Volume and Subcutaneous Applications
Featured Solution

Drug Delivery Components for Large-Volume and Subcutaneous Applications

As subcutaneous self-administration and large-volume on-body delivery reshape the injectable drug landscape, Datwyler's drug delivery components support the next generation of auto-injectors, wearable devices, and prefilled syringe platforms. The first-to-market 20ml universal NeoFlex™ plunger is engineered for compatibility across major cartridge and syringe platforms, supporting manufacturers developing large-volume subcutaneous programs for the Chinese and global market. 
Additional Information

Continue Exploring

Access additional materials and information related to this event and Datwyler’s solutions.

Resource The Rise of Large-Volume Injectors in a Patient-Centric Era
→
Resource High-Performance Components for Biologic Drug Delivery
→
Resource Datwyler Healthcare Product Portfolio
→
Helpful Information

Frequently Asked Questions

What is API China?
API China is one of China's largest pharmaceutical trade exhibitions, gathering more than 60,000 professionals from 5,000+ API manufacturers, biopharma companies, CROs, CMOs, and CDMOs. It is one of the preferred platforms for both domestic and internationally focused Chinese pharmaceutical enterprises.
When is API China 2026?
API China 2026 takes place November 11–13 at the Wuhan International Exhibition Center in Wuhan, China.
Where can we find Datwyler at API China?
Datwyler exhibits at Booth #B4C45.
EVENT UPDATES

Stay informed on upcoming Datwyler events

Subscribe to receive updates on conferences, presentations, and opportunities to connect with our team.